A new screening protocol can detect aggressive prostate cancers more selectively
Prostate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe.
Apr 10, 2024
0
2
Prostate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe.
Apr 10, 2024
0
2
A new article in JBMR Plus indicates that patient survival rates after hip or other bone fractures can be very poor. While patients and their families may dismiss a fracture as a minor injury, survival rates can be lower ...
Apr 9, 2024
0
1
Certain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated with higher risk of metastasis and/or recurrence of the disease, according to a study presented at the American ...
Apr 9, 2024
0
0
Removing one step from a three-part MRI scan, which could make them quicker, cheaper, and more accessible, had no negative impact on diagnostic accuracy, according to clinical trial results led by UCL and UCLH.
Apr 8, 2024
0
0
Microvascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to researchers at the Medical College of Georgia. Researchers presented their work at the American ...
Apr 8, 2024
0
0
SYNC-T, an investigational therapy that combines a device-induced vaccination at the tumor site with intratumoral infusion of a multitarget biologic drug led to numerous clinical responses in patients with metastatic castrate-resistant ...
Apr 8, 2024
0
0
Integrating magnetic resonance imaging (MRI) into prostate cancer (PCa) screening is associated with a reduction in unnecessary biopsies and overdiagnosis of insignificant disease, according to a review published online April ...
Apr 8, 2024
0
1
The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of ...
Apr 6, 2024
0
122
A simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.
Apr 5, 2024
0
0
Patients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a study published online March 19 in the Journal of the American Academy of Dermatology.
Apr 4, 2024
0
0